Search Results
Addition of docetaxel to initial hormone therapy improves survival in prostate cancer
Docetaxil in hormone therapy improves survival in metastatic, hormone-sensitive prostate cancer
Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review
Dr. Sandler Discusses Docetaxel With Hormonal and Radiation Therapy in Patients With Prostate Cancer
ARASENS: dialuramide plus ADT and docetaxel for metastatic hormone-sensitive prostate cancer
Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Hormone-Sensitive Pro...
Dr. Kantoff on Evolving Role of Docetaxel in Prostate Cancer Treatment
PEACE-1 points to benefit of adding abiraterone to ADT–docetaxel in de novo mCSPC | Karim Fizazi
Exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
STAMPEDE: Docetaxel and zoledronic acid (Results for patients)
Prostate Cancer: Research shows new treatment option offers improved survival
